Kur pirkti

ASBIS tiekia didelį asortimentą IT produktų savo klientams Lietuvoje. Aplankykite skilti kur pirkti ir sužinokite kur yra artimiausia parduotuvė

ASBIS naujienos

Liepa 25, 2022
ASBIS clients will now get access to IP Infusion’s leading networking software ...
Liepa 21, 2022
Q3 Distributor Points Promotions Now Available!
Birželis 29, 2022
ASBIS will offer Edgecore’s networking solutions to its clients in the EMEA ...
Birželis 17, 2022
The vendor was noted in two categories for its security, compliance, and ...
Gegužė 31, 2022
The European Hardware Association (EHA) has announced the devices and ...
Gegužė 23, 2022
Value-Added Distributor adds one more country to the 18 where it already offers ...
Gegužė 16, 2022
Habana Gaudi2 processor demonstrates two-times throughput over Nvidia’s A100 GPU
Gegužė 16, 2022
Elevated performance in every class. Powered by AMD RDNA™ 2 architecture, ...
Gegužė 16, 2022
Value-added distributor strengthened its storage portfolio with the fastest ...
ASBIS partners with IP Infusion in the EMEA region

Liepa 25, 2022

ASBIS, IP Infusion

ASBIS partners with IP Infusion in the EMEA region

ASBIS clients will now get access to IP Infusion’s leading networking software and solutions

In June 2022, value-added distributor ASBIS signed a distribution agreement with IP Infusion, further expanding its portfolio of networking solutions with industry-leading software products. The authorized area covers the EMEA region and includes all the 27 countries where ASBIS operates.

IP Infusion is a leading provider of open networking software and solutions for carriers, service providers, and data center operators. IP Infusion’s flagship OcNOS software is ranked as the industry’s Network Operating System (NOS) leader, enabling network operators to disaggregate their networks to accelerate innovation, streamline operations, and reduce Total Cost of Ownership (TCO).

Network OEMs may also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier-grade robustness. IP Infusion’s software is market mature with over 500 customers and over 10,000 carrier-grade deployments for aggregation, disaggregated cell site gateways, provider edge routing, optical transport networks, data center networking and more.

“This is a great addition to our portfolio of networking solutions, and this agreement will help us bring even more value to our clients across many regions. ASBIS is happy to welcome IP Infusion as its partner and we are ready to do our best for a mutually successful future!” - commented Marek Horyl, Product Marketing Director at ASBIS.

“We are pleased to partner with ASBIS in the EMEA market to extend our reach in the EMEA regions through ASBIS’ distribution channel,” said Tom Savoie, Chief Sales Officer for IP Infusion. “Together IP Infusion and ASBIS offer powerful disaggregated software solutions for our customers to receive the promise and benefits of open networking.”

 

About ASBIS

ASBISC Enterprises PLC (WSE: ASB) is a leading Value Add Distributor, OEM, and Solutions Provider of IT, IoT, IoT, and AI across CEE, FSU, and MEA. The company specializes in value-added distribution (VAD), B2B market solutions and ICT products distribution from global suppliers. As IT industry leaders, the Group’s expert teams configure hardware products and software elements, cloud-based services, and technologies to create commercially viable solutions of choice. For more information, visit the company's website at www.asbis.com.

About IP Infusion

IP Infusion is a leading provider of open network software and solutions for carriers, service providers and data center operators. Our solutions enable network operators to disaggregate their networks to accelerate innovation, streamline operations, and reduce Total Cost of Ownership (TCO). Network OEMs may also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier grade robustness. IP Infusion is headquartered in Santa Clara, Calif., and is a wholly owned and independently operated subsidiary of ACCESS CO., LTD. Additional information can be found at http://www.IPInfusion.com.

Disclaimer:: The information contained in each press release posted on this site was factually accurate on the date it was issued. While these press releases and other materials remain on the Company's website, the Company assumes no duty to update the information to reflect subsequent developments. Consequently, readers of the press releases and other materials should not rely upon the information as current or accurate after their issuance dates.